Advertisement

Search Results

Advertisement



Your search for Alice Goodman matches 6 pages

Showing 1 - 6


prostate cancer
issues in oncology

Prostate Health Index May Provide New Tool to Identify Patients Assigned to Watchful Waiting Who Require Immediate Treatment

A simple tool called “phi” appears to be able to identify which patients assigned to active surveillance for prostate cancer are more likely to require treatment. Phi, or the prostate health index, is calculated from three serum measurements: PSA, free/total PSA, and a new measurement,...

prostate cancer

Prolonged Hormone Therapy Exposure Increases Risk of Diabetes and Cardiovascular Disease in Older Patients With Prostate Cancer

Although androgen deprivation therapy extends survival in men with prostate cancer, its use is associated with unwanted side effects. In addition to the well-known side effects of impaired sexual function and hot flashes, prolonged exposure to androgen deprivation therapy can also lead to diabetes...

prostate cancer

Study Examines Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

In the randomized, phase III CA184-043 trial, ipilimumab (Yervoy) improved progression-free survival and prostate-specific antigen (PSA) response compared with placebo, but failed to improve overall survival significantly in postdocetaxel metastatic castration-resistant prostate cancer....

prostate cancer

Radiation Plus Hormone Therapy Extends Survival in Patients With High-Risk Prostate Cancer

The addition of radiation to lifelong hormone therapy with oral antiandrogens vs antiandrogens alone reduced the prostate cancer–specific death rate by more than 50% at 10 and 15 years in men with locally advanced prostate cancer, according to an updated analysis of the Scandinavian Prostate...

prostate cancer

Enzalutamide Improves Survival in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Enzalutamide (Xtandi) improved survival by 29% in men with chemotherapy-naive metastatic castration-resistant prostate cancer and reduced the risk of radiographic progression by 81%, according to complete results of the randomized, double-blind, placebo-controlled, multinational, phase III PREVAIL...

prostate cancer
issues in oncology

ECC 2013: French Study Finds Routine PSA Screening Does More Harm Than Good

There is no consensus on the value of routine prostate-specific antigen (PSA) screening. Weighing in on this issue, investigators presented a study at the European Cancer Congress 2013 in Amsterdam (Abstract 1481) suggesting that population-based PSA screening does more harm than good. The...

Advertisement

Advertisement



;
Advertisement